These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22612850

  • 21. Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?
    Ahouansou N, Georges M, Beltramo G, Aswad N, Hassani Y, Bonniaud P.
    Infect Dis Now; 2021 Oct; 51(7):618-621. PubMed ID: 33870898
    [Abstract] [Full Text] [Related]

  • 22. [Acute eosinophilic pneumonia secondary to daptomycin].
    Montenegro O, Del Campo R, Del Rio JJ, Ambrós Checa A.
    Enferm Infecc Microbiol Clin; 2016 Oct; 34(6):390-1. PubMed ID: 26530225
    [No Abstract] [Full Text] [Related]

  • 23. Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
    Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED.
    Ann Pharmacother; 2013 Apr; 47(4):537-42. PubMed ID: 23535814
    [Abstract] [Full Text] [Related]

  • 24. Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System.
    Okada N, Niimura T, Saisyo A, Kawaguchi Y, Ishizawa K, Kitahara T.
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad414. PubMed ID: 37601729
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Daptomycin associated eosinophilic pneumonia.
    Fernández-González R, Díaz López MD, Lorenzo Vizcaya AM, González Noya A.
    Med Clin (Barc); 2021 Feb 12; 156(3):148-149. PubMed ID: 32098706
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An elderly man with fever, dyspnoea and eosinophilia.
    Zheng S.
    Eur J Intern Med; 2019 Jul 12; 65():e5-e6. PubMed ID: 30904434
    [No Abstract] [Full Text] [Related]

  • 32. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA, Humphries JE, Crean S, Reynolds MW.
    Pharmacoepidemiol Drug Saf; 2010 Feb 12; 19(2):107-14. PubMed ID: 20014051
    [Abstract] [Full Text] [Related]

  • 33. Is a High Baseline Inflammatory Burden the Major Driver in Causing Daptomycin-induced Eosinophilic Pneumonia and Muscular Toxicity?
    Gatti M, Pea F.
    Clin Infect Dis; 2024 Oct 15; 79(4):1122-1123. PubMed ID: 38236203
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.
    Hochberg AM, Pearson RK, O'Hara DJ, Reisinger SJ.
    Drug Saf; 2009 Oct 15; 32(2):137-46. PubMed ID: 19236120
    [Abstract] [Full Text] [Related]

  • 40. Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia.
    Ishikawa K, Matsuo T, Tsuda Y, Rahman M, Uehara Y, Mori N.
    Antibiotics (Basel); 2022 Feb 16; 11(2):. PubMed ID: 35203855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.